BIO.B
What one share of Bio-Rad Laboratories holds
Laboratory Analytical Instruments
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $96.21 |
|---|---|
| Profit | $8.26 |
| Capex (buildings and equipment) | $5.18 |
| Free cash flow | $13.12 |
| Cash and investments | $19.33 |
| Debt | $30.36 |
| Book value | $268.22 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $69.76 | $0.88 | $4.77 | $2.52 | — | $87.61 |
| 2017 | $71.93 | $4.07 | $3.71 | −$0.24 | — | $98.81 |
| 2018 | $75.74 | $12.10 | $4.29 | $5.15 | — | $134.75 |
| 2019 | $76.59 | $58.27 | $3.26 | $11.91 | — | $192.90 |
| 2020 | $84.40 | $126.47 | $3.60 | $15.80 | — | $332.23 |
| 2021 | $96.75 | $140.83 | $4.43 | $17.73 | — | $458.76 |
| 2022 | $94.08 | −$121.79 | $3.79 | $2.74 | — | $322.82 |
| 2023 | $91.45 | −$21.82 | $5.36 | $7.47 | — | $299.26 |
| 2024 | $90.97 | −$65.36 | $5.87 | $10.26 | — | $232.84 |
| 2025 | $94.69 | $27.85 | $5.78 | $13.73 | — | $273.40 |